Cargando…
Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
Background: Biological agents (also termed biologics or biologicals) play a growingly central role in the treatment of immunological diseases. However, the numerous studies published on biologics complicate the decision on the most appropriate biologic for a given disease. We aim to address this pro...
Autores principales: | Kaegi, Celine, Steiner, Urs C., Wuest, Benjamin, Crowley, Catherine, Boyman, Onur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105675/ https://www.ncbi.nlm.nih.gov/pubmed/32265917 http://dx.doi.org/10.3389/fimmu.2020.00433 |
Ejemplares similares
-
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
por: Kaegi, Celine, et al.
Publicado: (2019) -
Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders
por: Kaegi, Celine, et al.
Publicado: (2022) -
Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
por: Isenberg, David A., et al.
Publicado: (2020) -
Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders
por: Arnold, Dennis D., et al.
Publicado: (2022) -
Kinetics of free and ligand-bound atacicept in human serum
por: Eslami, Mahya, et al.
Publicado: (2022)